-LDL HDL+
LIVE

Serial Number

79372661

Owner

Raydel Australia Pty Ltd

Attorney

Justin Lampel

Filing Date

May 25, 2023

Add to watchlist:

No watchlists yet
View on USPTO

-LDL HDL+ Trademark

Serial Number: 79372661 • Registration: 7518361

-LDL HDL+ is a trademark filed by Raydel Australia Pty Ltd on May 25, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Raydel Australia Pty Ltd

9-15 Chilvers Road

Entity Type: 82

Trademark Details

Filing Date

May 25, 2023

Registration Date

October 1, 2024

Published for Opposition

July 16, 2024

Goods & Services

Pharmaceutical preparations for the treatment of hyperlipidemia, atherosclerosis, heart disease, hypertension, cardiometabolic disease, thrombosis and cerebrovascular disease; dietetic food adapted for medical use; dietary supplements for humans; capsules, tablets, powders, and topical preparations of herbs, vitamins, minerals for medicinal use and pharmaceutical purposes for the treatment of hyperlipidemia, atherosclerosis, heart disease, hypertension, cardiometabolic disease, thrombosis and cerebrovascular disease; chemico-pharmaceutical preparations for the treatment of hyperlipidemia, atherosclerosis, heart disease, hypertension, cardiometabolic disease, thrombosis and cerebrovascular disease; liquid herbal and vitamin dietary supplements; dietetic food, namely, dietary and nutritionally fortified food products adapted for medical purposes; food supplements consisting of amino acids, vitamins and trace elements; food supplements, namely, antioxidants; dietetic beverages containing added herbal extracts, vitamins or minerals adapted for medical purposes; pharmaceutical compositions for the treatment of hyperlipidemia, atherosclerosis, heart disease, hypertension, cardiometabolic disease, thrombosis and cerebrovascular disease; pharmaceutical preparations, namely, drug delivery agents in the form of a coating for tablets and capsules that facilitate the delivery of a wide range of pharmaceuticals; pharmaceutical substances for the treatment of hyperlipidemia, atherosclerosis, heart disease, hypertension, cardiometabolic disease, thrombosis and cerebrovascular disease; pharmaceutical preparations, namely, gels for the treatment of hyperlipidemia, atherosclerosis, heart disease, hypertension, cardiometabolic disease, thrombosis and cerebrovascular disease; plant and herb extracts, other than essential oils, for medical purposes; nutritional supplements; healthcare products, namely, medicated toothpaste, medicated shampoo, medicated liquid bath soap; herbal and plant compounds and isolates, other than essential oils, for medicinal purposes; homeopathic pharmaceutical preparations for the treatment of hyperlipidemia, atherosclerosis, heart disease, hypertension, cardiometabolic disease, thrombosis and cerebrovascular disease; medicinal herbs and extracts of medicinal herbs, other than essential oils; medicines based on plant extracts, other than essential oils; natural healthcare preparations, namely, medicated toothpaste, medicated shampoo, medicated liquid bath soap; natural medicinal preparations, namely, medicated toothpaste, medicated shampoo, medicated liquid bath soap; medicinal preparations for the mouth to be applied in the form of tablets

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 19, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 8, 2025 FICS
FINAL DISPOSITION PROCESSED
Mar 8, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 1, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 1, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 1, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 16, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jul 16, 2024 PUBO
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 16, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jul 16, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 26, 2024 NONP
INTERNATIONAL REGISTRATION RENEWED
Jun 21, 2024 RNWL
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 7, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 7, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 7, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 7, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 7, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 27, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 27, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 27, 2024 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 29, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Apr 29, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 29, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 29, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 29, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 29, 2024 COAR
REFUSAL PROCESSED BY IB
Apr 8, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 19, 2024 RFCS
REFUSAL PROCESSED BY MPU
Mar 19, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 28, 2024 RFCR
NON-FINAL ACTION WRITTEN
Feb 27, 2024 CNRT
ASSIGNED TO EXAMINER
Feb 20, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 28, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 24, 2023 NWOS
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jun 22, 2023 SDRC